Information for the public
Anhydrous sodium thiosulfate (Pedmarqsi) is available on the NHS. It is a possible treatment for preventing hearing loss caused by cisplatin chemotherapy. It is suitable for babies, children and young people (1 month to 17 years) with solid tumours that are localised (have not spread to other parts of the body).
Is this treatment right for me or my child?
Your healthcare professionals should give you clear information, talk with you about the options and listen carefully to your views and concerns. See our webpage on making decisions about your care.
Questions to think about
- How well does it work compared with other treatments?
- What are the risks or side effects? How likely are they?
- How will the treatment affect day-to-day life?
- What happens if the treatment does not work?
- What happens if the treatment is not wanted? Are there other treatments available?
Information and support
The NHS webpage on hearing loss may be a good place to find out more.
These organisations can give you advice and support:
- Royal National Institute for Deaf People (RNID), 0808 808 0123
- National Deaf Children’s Society, 0808 800 8880
You can also get support from your local Healthwatch.
NICE is not responsible for the quality or accuracy of any information or advice provided by these organisations.
ISBN: 978-1-4731-6789-6
This page was last updated: